Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle LaPorte

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 17, 2017
Anticoagulation in Cancer PatientsAlexandra Schaller, Kyle LaPorte
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 30, 2019
Pharmacology Focus: CAR-T Cell Therapy in B-Cell LymphomasMichaela Hertz, Kali Bendix, Kyle LaPorte
South Dakota Medicine : the Journal of the South Dakota State Medical Association|January 7, 2022
Pharmacology Focus: Vaccination Considerations for Patients with CancerKyle LaPorte, Rachel Propst, Nathan Tvedten
Current Medicinal Chemistry|September 3, 2013
Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cellsLiang Han, Bo Peng, Qingyong Ma, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 17, 2017
Anticoagulation in Cancer PatientsAlexandra Schaller, Kyle LaPorte
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 30, 2019
Pharmacology Focus: CAR-T Cell Therapy in B-Cell LymphomasMichaela Hertz, Kali Bendix, Kyle LaPorte
South Dakota Medicine : the Journal of the South Dakota State Medical Association|January 7, 2022
Pharmacology Focus: Vaccination Considerations for Patients with CancerKyle LaPorte, Rachel Propst, Nathan Tvedten
Current Medicinal Chemistry|September 3, 2013
Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cellsLiang Han, Bo Peng, Qingyong Ma, et al.
Pageof 1